Even while compiling this monograph, the paradigms of how cell-based therapeutics affect neurological injury have been changing. Mechanisms that seemed reasonable and well-supported are being re-examined, and this necessarily drives the movement toward various clinical trial plans. The earliest clinical trials are beginning, and as this monograph goes to press, Phase 2 studies in TBI and stroke will begin. The developments in the field may ultimately offer realistic hope for improvement in patients with severe injuries, and the work on these vexing problems will be the key to unlocking future treatments.
Contents
1 Basics of Stem and Progenitor Cells
2 Progenitor Cell Tissue Engineering
3 Stem Cell Delivery Methods and Routes
4 Neural Progenitor Cells for Traumatic Brain and Spinal Cord Injury: Endogenous Cell Rescue Versus Replacement Mechanisms
5 Traumatic Brain Injury Pathophysiology/Model
6 Traumatic Brain Injury: Relationship of Clinical Injury to Progenitor Cell Therapeutics
7 Cell-Based Therapy for Stroke
8 Spinal Cord Injury Pathophysiology and Progenitor Cell Therapy
9 Progenitor Cell Therapy for the Treatment of Central Nervous System Injury: A Review of the State of Current Clinical Trials
Index
Product Details
- Hardcover: 255 pages
- Publisher: Humana Press; 1st edition (November 17, 2010)
- Language: English
- ISBN-10: 1607619644
- ISBN-13: 978-1607619642
- Product Dimensions: 9.2 x 6.2 x 0.7 inches